This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Secondary Progressive MS: Recognition and Management

Secondary Progressive MS: Recognition and Management

Format

Patient Case Study

Time to Complete

30 minutes

Released

June 28, 2019

Expires

June 28, 2020
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 Credit(s)TM
0.50 / CNE Contact Hour
0.50 / CE for Pharmacists

Accredited Provider


This activity is provided by The France Foundation

Commercial Supporter

This activity is supported by educational grants from Biogen, Celgene, and Sanofi Genzyme.

Program Description

A patient with MS presents in the clinical care center with worsening symptoms. Patricia Coyle, MD, and Patricia Melville, RN, MSN, review the key diagnosis criteria, treatment options, and discuss counseling options using shared decision-making with the patient. This interactive case study provides numerous resources for the learner.

Intended Audience

This activity is intended for neurologists, advanced practice providers, nurses, pharmacists, and other members of the MS care team.

Educational Objective

At the end of this CE activity, participants should be able to:

  • Explain MOAs and considerations and precautions surrounding new and emerging agents for RRMS and SPMS
  • Provide evidence-based rationale for initial or subsequent treatment choices, as well as their timing
  • Formulate a management plan that includes strategies and practical tools which support shared decision-making (SDM)

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in healthcare and not those of a commercial interest.

Faculty

Patricia Coyle, MD
Professor of Neurology and Vice Chair of Clinical Affairs
Director, MS Comprehensive Care Center
Stony Brook Neurosciences Institute
Stony Brook, NY

Dr. Coyle has done non-CE consulting for Accordant, Actelion, Alexion, Bayer, Biogen, Celgene, Genentech/Roche, Novartis, Sanofi Genzyme, Serono, and TG Therapeutics. She has also done contract research for Actelion, Alkermes, Genentech/Roche, MedDay, NINDS, and Novartis.

Patricia Melville, RN, MSN, NP-C, MSCN
Clinical Instructor, Department of Neurology
SUNY at Stony Brook
Stony Brook MS Comprehensive Care Center
Stony Brook, NY

Ms. Melville has served on advisory boards for Biogen, Genentech, and Sanofi Genzyme. She has also served on the speaker bureau for Biogen, EMD Serono, Genentech, Sanofi Genzyme, and Novartis.

Marie Moore, MSN
Nurse Practitioner
Neurology, Carolinas Healthcare System
Charlotte, NC

Ms Moore has served on advisory boards for Celgene and Genzyme and has served on the speakers’ bureau for Genzyme.

Khamini Guillermo, DNP, CRNP, MSN
Family Nurse Practitioner
Ursinus College Wellness Center
Collegeville, PA

Ms. Guillermo has no relevant financial relationships to disclose.

Jacci Bainbridge, PharmD, FCCP
Professor, Department of Clinical Pharmacy and Neurology
Anschutz Medical Campus, University of Colorado
Aurora, CO

Dr. Bainbridge serves on the advisory board for Genentech.

Accredited Provider Disclosures

The following staff report that they have relevant financial relationships to disclose:
Janis Vajdos, MS has a spouse who works for Pfizer, Inc., and they hold stock in Pfizer, Inc.

The other planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.50

Type

CNE Contact Hour(s)

Accreditation Statement

Montana Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This enduring activity is designated for 0.50 contact hours.

Credit

0.50

Type

CE for Pharmacists

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and will award 0.50 contact hours (0.05 CEUs).

ACPE No. 0391-0000-19-131-H01-P.

ADDITIONAL CREDIT INFORMATION

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM   through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Instructions

1. There are no fees for participating in and receiving credit for this activity.
2. Review the activity objectives and CME/CE information.
3. Complete the CME/CE activity
4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs.

6. Credit documentation/reporting:

  • If you are requesting AMA PRA Category 1 CreditsTM , ANCC credit, or a certificate of participation—your CME/CE certificate will be available for download.
  • If you are requesting ACPE pharmacy credit—your CE credits will be submitted electronically to the CPE Monitor.
If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at
http://www.francefoundation.com/privacy.

myCME privacy policy
Add to Queue


Related to this activity